Donepezil Hydrochloride Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 5 mg, 10 mg, 23 mg

Reference Brands: Aricept (USA/EU)

Category: Neurology

Donepezil Hydrochloride is available in Tablets and strengths such as 5 mg, 10 mg, 23 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Donepezil Hydrochloride is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Donepezil Hydrochloride can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Donepezil Hydrochloride is a piperidine derivative and a centrally acting, rapid, and reversible acetylcholinesterase inhibitor primarily used in the treatment of Alzheimer’s disease. It works by inhibiting acetylcholinesterase, the enzyme responsible for breaking down acetylcholine after its release at synaptic junctions. By reversibly binding to this enzyme, donepezil prevents acetylcholine hydrolysis, leading to increased availability of acetylcholine at synapses and enhanced cholinergic neurotransmission in the brain. This mechanism supports improved communication between nerve cells involved in memory and cognition. Donepezil Hydrochloride is approved by the U.S. Food and Drug Administration for the treatment of mild, moderate, and severe dementia associated with Alzheimer’s disease. While it does not alter the underlying progression of the disease, it has demonstrated clinical benefit in alleviating symptoms by improving cognitive function, behavior, and daily functioning in affected individuals. In addition to its approved indication, donepezil is also utilized in various off-label clinical applications. The medication is administered orally and requires appropriate monitoring for adverse effects, drug interactions, and patient response. Donepezil Hydrochloride remains a cornerstone therapy in the symptomatic management of Alzheimer’s disease in clinical practice.